# US 2016/0355524 A1 · Phillygenol sulphate and derivative thereof, and preparation method and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355524 A1
- Document ID: US20160355524A1
- Status: Published application
- Kind: A1
- Application number: 15/036,613
- Filed: 2014-11-06
- Published: 2016-12-08
- Earliest claimed: 2013-11-18
- Assignees: Li FU
- Inventors: Li Fu; Hongyu Fan; Shuo Wang
- Web page: https://patentgrep.com/patent/US20160355524A1

## CPC

- C07D 493/04: Ortho-condensed systems
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/16: for influenza or rhinoviruses
- A61P 31/22: for herpes viruses
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a forsythiaside sulfate derivatives as represented by the following formula, the preparation method and antiviral application thereof:

## Claims

### Claim 1

A forsythiaside sulfate and its derivatives as represented by the following chemical structural formula,
wherein R is H, Na+, K+, NH4+, tetramethyl ammonium, tetraethyl ammonium, methyl amino, dimethylamino, trimethylamino, triethylamino, diethylamino, ethylamino, ethanolamino, diethanolamino, piperidyl, piperazinyl or pyrazinyl.

### Claim 2 (depends on 1)

A preparation method of the forsythiaside sulfate and derivatives thereof according to claim 1, comprising the following sequentially performed steps:
1) dissolving forsythiaside in an organic solvent to obtain a forsythiaside solution;
2) first adding a sulfating agent into the forsythiaside solution and mixing well; and then, carrying out an esterification reaction to obtain a product mixture liquid;
3) adding a base to adjust the pH value of the mixture liquid to 8-10; and
4) separating and purifying the mixture liquid to obtain the final product.

### Claim 3 (depends on 2)

The preparation method according to claim 2, wherein the sulfating agent in step 2) is selected from chlorosulfonic acid, sulfur trioxide-triethylamine complex, sulfur trioxide-pyridine complex or sulfur trioxide-trimethylamine complex.

### Claim 4 (depends on 2)

The preparation method according to claim 2, wherein the base in step 3) is selected from organic base or inorganic base.

### Claim 5 (depends on 2)

The preparation method according to claim 2, wherein the organic solvent in step 1) is selected from one of pyridine, N,N-dimethylformamide, N,N-dimethylacetamide or dichloromethane.

### Claim 6 (depends on 2)

The preparation method according to claim 2, wherein the sulfating agent is added in the forsythiaside solution at a temperature of 0-5° C. in step 2).

### Claim 7 (depends on 2)

The preparation method according to claim 2, wherein a molar ratio of the forsythiaside in the forsythiaside solution to the sulfating agent in step 2) is 1:1-10.

### Claim 8 (depends on 1)

An application of the forsythiaside sulfate and derivatives thereof according to claim 1 in preparation of antiviral drugs.

### Claim 9 (depends on 8)

The application according to claim 8, wherein the antiviral drugs are selected from anti-influenza drugs, anti-parainfluenza drugs, anti-respiratory syncytial virus drugs, anti-herpes simplex virus type-I drugs and anti-coxsackievirus A16 drugs.

### Claim 10

An antiviral drug, comprising a forsythiaside sulfate or forsythiaside sulfate derivatives.
